Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
1.910
-0.040 (-2.05%)
At close: Jun 20, 2025, 4:00 PM
1.920
+0.010 (0.52%)
After-hours: Jun 20, 2025, 4:04 PM EDT
Adagene Market Cap
Adagene has a market cap or net worth of $89.51 million as of June 20, 2025. Its market cap has decreased by -23.80% in one year.
Market Cap
89.51M
Enterprise Value
22.81M
1-Year Change
-23.80%
Ranking
Category
Stock Price
$1.91
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $89.51M, a decrease of -88.87%. That is a compound annual growth rate of -39.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 89.51M | 1.60% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.73B |
| Johnson & Johnson | 360.41B |
| AbbVie | 327.31B |
| Novo Nordisk | 326.28B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 231.38B |
| Novartis AG | 227.54B |
| AstraZeneca | 217.06B |